A Dose-ranging Study to Evaluate the Safety and Efficacy of UNR844 in Subjects With Presbyopia.

NCT04806503 · clinicaltrials.gov ↗
PHASE2
Phase
TERMINATED
Status
234
Enrollment
INDUSTRY
Sponsor class

Stopped The study was discontinued by the Sponsor because it did not achieve the primary objective.

Conditions

Interventions

Sponsor

Novartis Pharmaceuticals